Antagonism of the TXA2 receptor by Seratrodast (cas 112665-43-7) : A structural approach
-
Add time:07/26/2019 Source:sciencedirect.com
The crystal structure of Seratrodast (cas 112665-43-7) (AA-2414), a potent thromboxane A2 (TXA2) receptor antagonist, served as starting point to docking studies with the modeled human TXA2 receptor. This structural approach provides rational basis for the design of new antagonists within the aryl sulfonamide family.
We also recommend Trading Suppliers and Manufacturers of Seratrodast (cas 112665-43-7). Pls Click Website Link as below: cas 112665-43-7 suppliers
Prev:A kinetic and thermodynamic study of Seratrodast (cas 112665-43-7) polymorphic transition by isothermal microcalorimetry
Next:Synthesis and antimicrobial properties of 3-aryl-1-(1,1′-biphenyl-4-yl)-2-(1H-imidazol-1-yl)propanes as ‘carba-analogues’ of the N-arylmethyl-N-[(1,1′-biphenyl)-4-ylmethyl])-1H-imidazol-1-amines, a new class of antifungal agents) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- A kinetic and thermodynamic study of Seratrodast (cas 112665-43-7) polymorphic transition by isothermal microcalorimetry07/25/2019
- Isolation and structure elucidation of the major photodegradation products of Seratrodast (cas 112665-43-7)07/24/2019
- High-performance liquid chromatographic determination of Seratrodast (cas 112665-43-7) and its metabolites in human serum and urine07/23/2019